Valuation : Hikma Pharmaceuticals PLC

Market Cap 4.65B 3.99B 3.74B 3.42B 6.45B 444B 6.47B 44.29B 17.31B 224B 17.47B 17.1B 741B P/E 2026 *
12x
P/E 2027 * 10.7x
Enterprise Value 6.12B 5.26B 4.92B 4.51B 8.49B 585B 8.51B 58.27B 22.78B 295B 22.99B 22.49B 975B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.65x
Free-Float
63.17%
Yield 2026 *
3.9%
Yield 2027 * 4.13%
1 day-0.12%
1 week-2.11%
Current month+2.40%
1 month+2.92%
3 months+9.66%
6 months+18.21%
Current year+4.71%
1 week 1,607.8
Extreme 1607.8
1,664
1 month 1,563
Extreme 1563
1,755
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
1,865
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,625
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 01/12/2025
Director of Finance/CFO - 26/02/2026
Chief Tech/Sci/R&D Officer 64 26/02/2026
Director TitleAgeSince
Director/Board Member 69 14/10/2005
Director/Board Member 54 15/12/2025
Chairman 69 15/05/2014
Date Insider Type Main position Quantity % Market Cap.
19/12/25 Buy

Director

100,000 0.0451%
11/11/25 Buy

Chief Executive Officer

70,000 0.0315%
11/11/25 Buy

Chief Executive Officer

100,000 0.0451%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-2.11%-10.82%-24.90% 4.65B
-1.12%-5.49%+60.19%+112.43% 1,048B
-1.57%-0.60%+50.33%+59.86% 640B
-1.81%-1.41%+24.07%+75.98% 456B
-0.10%-3.33%+39.12%+40.11% 362B
+0.18%-2.07%+22.89%+37.94% 295B
+0.26%+0.71%+2.22%+12.32% 255B
-0.76%+0.75%+51.75%+70.45% 236B
+1.62%-0.47%-16.54%-53.68% 204B
+0.52%+3.78%+30.67%+93.68% 185B
Average -0.30%-0.62%+25.39%+42.42% 368.63B
Weighted average by Cap. -0.73%-1.92%+38.59%+65.81%

Financials

2026 *2027 *
Net sales 3.46B 2.97B 2.78B 2.55B 4.8B 331B 4.81B 32.95B 12.88B 167B 13B 12.72B 552B 3.6B 3.09B 2.89B 2.65B 4.99B 344B 5.01B 34.28B 13.4B 173B 13.52B 13.23B 574B
Net income 412M 354M 331M 303M 571M 39.37B 573M 3.92B 1.53B 19.84B 1.55B 1.51B 65.67B 453M 389M 364M 334M 629M 43.31B 630M 4.31B 1.69B 21.83B 1.7B 1.67B 72.23B
Net Debt 1.47B 1.26B 1.18B 1.08B 2.04B 140B 2.04B 13.98B 5.46B 70.7B 5.51B 5.4B 234B 1.29B 1.11B 1.04B 952M 1.79B 124B 1.8B 12.31B 4.81B 62.26B 4.86B 4.75B 206B
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and specialty pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Hikma Rx. It supplies hospitals across North America, Europe and the Middle East and North Africa (MENA) region with generic injectable and specialty medicines, supported by its growing global manufacturing network. It supplies branded generic and in-licensed products from its local manufacturing facilities to retail and hospital customers across the MENA region. Through Hikma Rx, it supplies oral, respiratory and other generic and specialty products to the North American market. Its manufacturing facilities in the United States (US) supply products across a broad range of therapeutic areas, including respiratory, oncology and pain management, serving customers in both the US and Canada.
Employees
9,500
Date Price Change Volume
28/08/26 GBX 1,624.00 -0.25% 14,831
27/08/26 GBX 1,628.00 -0.73% 445,434
26/08/26 GBX 1,640.00 0.00% 862,660
25/08/26 GBX 1,640.00 +0.43% 349,026
24/08/26 GBX 1,633.00 -0.18% 680,937
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
22.12USD
Average target price
25.78USD
Spread / Average Target
+16.53%

Quarterly revenue - Rate of surprise